Skip to main content

Gilles Salles, MD, PhD

Gilles Salles, MD, PhD
Videos
11/27/2023
Gilles Salles, MD, PhD, highlights findings from the phase 3 SELENE trial, which aimed to assess the value of adding ibrutinib to chemotherapy among patients with previously treated follicular lymphoma or marginal zone lymphoma.
Gilles Salles, MD, PhD, highlights findings from the phase 3 SELENE trial, which aimed to assess the value of adding ibrutinib to chemotherapy among patients with previously treated follicular lymphoma or marginal zone lymphoma.
Gilles Salles, MD, PhD,...
11/27/2023
Oncology
Gilles Salles, MD, PhD
Videos
01/15/2024
Gilles Salles, MD, PhD, offers advice for fellow oncologists in the B-cell lymphoma space, highlighting the need for strategically chosen therapies to minimize the risk of transformations.
Gilles Salles, MD, PhD, offers advice for fellow oncologists in the B-cell lymphoma space, highlighting the need for strategically chosen therapies to minimize the risk of transformations.
Gilles Salles, MD, PhD, offers...
01/15/2024
Oncology